<DOC>
	<DOCNO>NCT01309555</DOCNO>
	<brief_summary>This Australian , Multicentre , Observational Registry study Adherence Long Term Outcomes Therapy paediatric subject use easypod™ electromechanical device growth hormone treatment assess level adherence subject receive SAIZEN® via easypod™ .</brief_summary>
	<brief_title>To Assess Level Adherence Subjects Receiving SAIZEN® Via Easypod™ Australia</brief_title>
	<detailed_description>Subjects enrol multicenter longitudinal observational registry . Parents/subjects provide Informed Consent/assent upload data populationbased analysis optionally adhere patient adherence support program design improve adherence , ultimately , clinical outcome . Adherence data primarily derive easypod™ device combine physician data entry outcome measure . Data collect retrospectively prospectively . This allow establishment adherence profile explore hypothesis patient adherence support program improve adherence subsequent clinical outcome . Collected data also analyze multinational pooled analysis comparable national study . Primary Objective : • To assess level adherence subject receive SAIZEN® via easypod™ Secondary Objectives : - To describe impact adherence clinical outcome subject receive SAIZEN® via easypod™ - To identify adherence subject profiling base age , gender , self injection , time treatment , medical history time enrollment - To assess impact adherence Insulin-like Growth Factor 1 ( IGF1 ) ( , within normal range )</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Administered growth hormone via easypod™ electromechanical device accord SAIZEN® Product Information Aged 2 18 year Appropriate Informed Consent/Assent provide Subjects mature bone age take growth hormone ( i.e . take growth hormone metabolic effect ) Contraindications SAIZEN® define SAIZEN® Product Information Use investigational drug participation another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Growth disorder</keyword>
	<keyword>Saizen</keyword>
	<keyword>easypod™</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Pediatric subject</keyword>
</DOC>